Skip to main content
. 2022 May 16;23(10):5574. doi: 10.3390/ijms23105574

Figure 3.

Figure 3

Reduced BVR-A protein levels or impaired BVR-A activation occur with the progression of metabolic or neurodegenerative diseases. Reduced BVR-A protein levels or impaired BVR-A activation (reduced Tyr phosphorylation or increased nitration) are observed during the progression of either metabolic or neurodegenerative diseases and are associated with the dysfunction of insulin signaling.